there is growing awareness , as evidenced by recent reports , that heparin has a small but definite incidence of causing thrombocytopenia ( 6 to 8 days after initiation of therapy ) associated with platelet aggregation causing intravascular thrombosis , with potentially devastating morbidity and mortality .
C0019134
heparin
C0040034
thrombocytopenia